Treasurer of the State of North Carolina
MRNA icon

Treasurer of the State of North Carolina’s Moderna MRNA Stock Holding History

Treasurer of the State of North Carolina’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
154,987
+1,580
+1% +$81.7K 0.03% 456
2026
Q1 		$7.79M Buy
153,407
+3,266
+2% +$152K 0.02% 495
2025
Q4 		$4.43M Sell
150,141
-9,334
-6% -$254K 0.01% 651
2025
Q3 		$4.12M Sell
159,475
-6,214
-4% -$173K 0.01% 694
2025
Q2 		$4.57M Buy
165,689
+17,785
+12% +$468K 0.01% 669
2025
Q1 		$4.19M Sell
147,904
-58,980
-29% -$2.09M 0.02% 640
2024
Q4 		$8.6M Buy
206,884
+7,490
+4% +$358K 0.03% 445
2024
Q3 		$13.3M Buy
199,394
+4,800
+2% +$441K 0.05% 337
2024
Q2 		$23.1M Sell
194,594
-21,699
-10% -$2.75M 0.1% 181
2024
Q1 		$23M Sell
216,293
-2,150
-1% -$217K 0.1% 188
2023
Q4 		$21.7M Buy
218,443
+2,691
+1% +$226K 0.11% 185
2023
Q3 		$22.3M Buy
215,752
+2,451
+1% +$273K 0.12% 153
2023
Q2 		$25.9M Buy
213,301
+8,325
+4% +$1.11M 0.14% 139
2023
Q1 		$31.5M Buy
204,976
+10,649
+5% +$1.76M 0.18% 109
2022
Q4 		$34.9M Sell
194,327
-6,833
-3% -$1.12M 0.21% 101
2022
Q3 		$23.8M Sell
201,160
-3,342
-2% -$507K 0.16% 128
2022
Q2 		$29.2M Buy
204,502
+2,099
+1% +$300K 0.18% 108
2022
Q1 		$34.9M Buy
202,403
+31,004
+18% +$5.22M 0.19% 104
2021
Q4 		$43.5M Buy
171,399
+6,598
+4% +$1.93M 0.23% 86
2021
Q3 		$63.4M Sell
164,801
-19,100
-10% -$7.04M 0.37% 50
2021
Q2 		$43.2M Buy
183,901
+18,800
+11% +$3.36M 0.25% 82
2021
Q1 		$21.6M Buy
165,101
+8,707
+6% +$1.26M 0.14% 149
2020
Q4 		$16.3M Sell
156,394
-45,940
-23% -$4.65M 0.11% 174
2020
Q3 		$14.3M Buy
202,334
+17,954
+10% +$1.25M 0.11% 177
2020
Q2 		$11.8M Buy
184,380
+92,260
+100% +$5.05M 0.1% 191
2020
Q1 		$2.76M Buy
92,120
+42,210
+85% +$971K 0.02% 523
2019
Q4 		$976K Buy
49,910
+1,060
+2% +$18.8K 0.01% 818
2019
Q3 		$778K Buy
48,850
+38,040
+352% +$562K 0.01% 868
2019
Q2 		$158K Buy
10,810
+60
+0.6% +$1.29K ﹤0.01% 1008
2019
Q1 		$219K Buy
+10,750
New +$200K ﹤0.01% 980

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Treasurer of the State of North Carolina's MRNA Position: Q2 2026 in Review

Treasurer of the State of North Carolina increased its Moderna (MRNA) stake by 1% in Q2 2026, buying an estimated $81.7K and bringing the position to 154,987 shares worth $10.9M. The position accounts for 0.03% of the portfolio, ranked #456.

Treasurer of the State of North Carolina first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $63.4M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Treasurer of the State of North Carolina held 154,987 shares of Moderna worth $10.9M as of Q2 2026.
  • Treasurer of the State of North Carolina bought 1,580 Moderna shares in Q2 2026, an estimated $81.7K.
  • Moderna made up 0.03% of Treasurer of the State of North Carolina's portfolio in Q2 2026, its #456 holding.
  • Treasurer of the State of North Carolina first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
  • Treasurer of the State of North Carolina's Moderna position peaked at $63.4M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.